Related Experiment Video

Updated: Dec 23, 2025

Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates
05:58

Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates

Published on: September 6, 2017

40.3K

Dramatic changes in blood protein levels during the first week of life in extremely preterm infants

Wen Zhong1, Hanna Danielsson2, Abdellah Tebani1

  • 1Science for Life Laboratory, Department of Protein Science, KTH - Royal Institute of Technology, Stockholm, Sweden.

Pediatric Research
|April 25, 2020
PubMed

Insights

Extremely preterm infants show a unique blood protein profile at birth that shifts significantly after birth. This study tracks these protein changes to improve understanding and care for vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Proteomics
  • Biochemistry

Background:

  • Preterm birth is a leading cause of mortality in children under five.
  • Survivors often experience significant short- and long-term health issues.
  • Novel protein analysis platforms offer new insights into infant health and disease.

Purpose of the Study:

  • To analyze protein profiles in extremely preterm infants.
  • To understand physiological changes during the transition from intrauterine to extrauterine life.
  • To identify potential biomarkers for early intervention.

Main Methods:

  • Longitudinal analysis of blood protein profiles in 14 extremely preterm infants.
  • Utilized a novel multiplex protein analysis platform.
  • Integrated medical variables with profiling of 448 unique protein targets.

Main Results:

  • Preterm infants exhibit a distinct, unified blood protein profile at birth.
  • This profile diversifies significantly within the first week and up to term-equivalent age.
  • Identified temporal trends in protein clusters, including liver and immune proteins.

Conclusions:

  • The identified protein profiles and temporal trends aid in understanding the intrauterine-extrauterine transition.
  • This knowledge is crucial for developing targeted early-life interventions.
  • Aims to promote normal development in vulnerable preterm infants.
Abstract

More Related Videos

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.5K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

444

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
669
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
248
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
698
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.6K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.1K